195 related articles for article (PubMed ID: 27121258)
1. Microsatellite polymorphism in the P1 promoter region of the IGF‑1 gene is associated with endometrial cancer.
Kwasniewski W; Gozdzicka-Jozefiak A; Wolun-Cholewa M; Polak G; Sierocinska-Sawa J; Kwasniewska A; Kotarski J
Mol Med Rep; 2016 Jun; 13(6):4950-8. PubMed ID: 27121258
[TBL] [Abstract][Full Text] [Related]
2. A comprehensive analysis of common IGF1, IGFBP1 and IGFBP3 genetic variation with prospective IGF-I and IGFBP-3 blood levels and prostate cancer risk among Caucasians.
Schumacher FR; Cheng I; Freedman ML; Mucci L; Allen NE; Pollak MN; Hayes RB; Stram DO; Canzian F; Henderson BE; Hunter DJ; Virtamo J; Manjer J; Gaziano JM; Kolonel LN; Tjønneland A; Albanes D; Calle EE; Giovannucci E; Crawford ED; Haiman CA; Kraft P; Willett WC; Thun MJ; Le Marchand L; Kaaks R; Feigelson HS; Bueno-de-Mesquita HB; Palli D; Riboli E; Lund E; Amiano P; Andriole G; Dunning AM; Trichopoulos D; Stampfer MJ; Key TJ; Ma J
Hum Mol Genet; 2010 Aug; 19(15):3089-101. PubMed ID: 20484221
[TBL] [Abstract][Full Text] [Related]
3. IGF-1, IGFBP-1, and IGFBP-3 polymorphisms predict circulating IGF levels but not breast cancer risk: findings from the Breast and Prostate Cancer Cohort Consortium (BPC3).
Patel AV; Cheng I; Canzian F; Le Marchand L; Thun MJ; Berg CD; Buring J; Calle EE; Chanock S; Clavel-Chapelon F; Cox DG; Dorronsoro M; Dossus L; Haiman CA; Hankinson SE; Henderson BE; Hoover R; Hunter DJ; Kaaks R; Kolonel LN; Kraft P; Linseisen J; Lund E; Manjer J; McCarty C; Peeters PH; Pike MC; Pollak M; Riboli E; Stram DO; Tjonneland A; Travis RC; Trichopoulos D; Tumino R; Yeager M; Ziegler RG; Feigelson HS;
PLoS One; 2008 Jul; 3(7):e2578. PubMed ID: 18596909
[TBL] [Abstract][Full Text] [Related]
4. Influence of polymorphisms in genes encoding for insulin-like growth factor (IGF)-I, insulin, and IGF-binding protein (IGFBP)-3 on IGF-I, IGF-II, and IGFBP-3 levels in umbilical cord plasma.
Landmann E; Kollerits B; Kreuder JG; Blum WF; Kronenberg F; Rudloff S
Horm Res Paediatr; 2012; 77(6):341-50. PubMed ID: 22739332
[TBL] [Abstract][Full Text] [Related]
5. A microsatellite polymorphism in IGF1 gene promoter and timing of natural menopause in Caucasian women.
Kaczmarek M; Pacholska-Bogalska J; Kwaśniewski W; Kotarski J; Halerz-Nowakowska B; Goździka-Józefiak A
Int J Med Sci; 2015; 12(1):32-41. PubMed ID: 25552916
[TBL] [Abstract][Full Text] [Related]
6. Genetic determinants of circulating insulin-like growth factor (IGF)-I, IGF binding protein (BP)-1, and IGFBP-3 levels in a multiethnic population.
Cheng I; DeLellis Henderson K; Haiman CA; Kolonel LN; Henderson BE; Freedman ML; Le Marchand L
J Clin Endocrinol Metab; 2007 Sep; 92(9):3660-6. PubMed ID: 17566087
[TBL] [Abstract][Full Text] [Related]
7. Analysis of cytosine-adenine repeats in P1 promoter region of IGF-1 gene in peripheral blood cells and cervical tissue samples of females with cervical intraepithelial lesions and squamous cervical cancer.
Kwasniewski W; Gozdzicka-Jozefiak A; Kotarska M; Polak G; Barczynski B; Broniarczyk J; Nowak W; Wolun-Cholewa M; Kwasniewska A; Kotarski J
Mol Med Rep; 2015 Feb; 11(2):766-74. PubMed ID: 25384883
[TBL] [Abstract][Full Text] [Related]
8. Common genetic variation in IGF1, IGFBP1 and IGFBP3 and ovarian cancer risk.
Terry KL; Tworoger SS; Gates MA; Cramer DW; Hankinson SE
Carcinogenesis; 2009 Dec; 30(12):2042-6. PubMed ID: 19858071
[TBL] [Abstract][Full Text] [Related]
9. Insulin/IGF and sex hormone axes in human endometrium and associations with endometrial cancer risk factors.
Merritt MA; Strickler HD; Einstein MH; Yang HP; Sherman ME; Wentzensen N; Brouwer-Visser J; Cossio MJ; Whitney KD; Yu H; Gunter MJ; Huang GS
Cancer Causes Control; 2016 Jun; 27(6):737-48. PubMed ID: 27125830
[TBL] [Abstract][Full Text] [Related]
10. Growth hormone pharmacogenetics: the interactive effect of a microsatellite in the IGF1 promoter region with the GHR-exon 3 and -202 A/C IGFBP3 variants on treatment outcomes of children with severe GH deficiency.
Costalonga EF; Antonini SR; Guerra G; Coletta RR; Franca MM; Braz AF; Mendonca BB; Arnhold IJ; Jorge AA
Pharmacogenomics J; 2012 Oct; 12(5):439-45. PubMed ID: 21468024
[TBL] [Abstract][Full Text] [Related]
11. Common genetic variation within IGFI, IGFII, IGFBP-1, and IGFBP-3 and endometrial cancer risk.
McGrath M; Lee IM; Buring J; De Vivo I
Gynecol Oncol; 2011 Feb; 120(2):174-8. PubMed ID: 21078522
[TBL] [Abstract][Full Text] [Related]
12. Up-regulation of genes involved in the insulin signalling pathway (IGF1, PTEN and IGFBP1) in the endometrium may link polycystic ovarian syndrome and endometrial cancer.
Shafiee MN; Seedhouse C; Mongan N; Chapman C; Deen S; Abu J; Atiomo W
Mol Cell Endocrinol; 2016 Mar; 424():94-101. PubMed ID: 26802879
[TBL] [Abstract][Full Text] [Related]
13. Polymorphisms in the P1 promoter of the IGF-1 gene in children with growth disorders.
Broniarczyk JK; Kędzia A; Nowak W; Kościński Ł; Lewandowski M; Goździcka-Józefiak A
Pediatr Endocrinol Diabetes Metab; 2015; 20(4):136-42. PubMed ID: 26615580
[TBL] [Abstract][Full Text] [Related]
14. Impact of IGF-1, IGF-1R, and IGFBP-3 promoter methylation on the risk and prognosis of esophageal carcinoma.
Ye P; Qu CF; Hu XL
Tumour Biol; 2016 May; 37(5):6893-904. PubMed ID: 26662570
[TBL] [Abstract][Full Text] [Related]
15. A polymorphic locus in the promoter region of the IGFBP3 gene is related to mammographic breast density.
Lai JH; Vesprini D; Zhang W; Yaffe MJ; Pollak M; Narod SA
Cancer Epidemiol Biomarkers Prev; 2004 Apr; 13(4):573-82. PubMed ID: 15066922
[TBL] [Abstract][Full Text] [Related]
16. Insulin-like growth factor-1 genotype predicts breast volume after pregnancy and hormonal contraception and is associated with circulating insulin-like growth factor-1 levels: implications for risk of early-onset breast cancer in young women from hereditary breast cancer families.
Jernström H; Sandberg T; Bågeman E; Borg A; Olsson H
Int J Gynecol Cancer; 2006; 16 Suppl 2():497. PubMed ID: 17010055
[TBL] [Abstract][Full Text] [Related]
17. Insulinlike Growth Factor-1 and Its Binding Protein-3 Polymorphisms Predict Circulating IGF-1 Level and Appendicular Skeletal Muscle Mass in Chinese Elderly.
Yang CW; Li TC; Li CI; Liu CS; Lin CH; Lin WY; Lin CC
J Am Med Dir Assoc; 2015 May; 16(5):365-70. PubMed ID: 25548030
[TBL] [Abstract][Full Text] [Related]
18. Phenotypes and genotypes of insulin-like growth factor 1, IGF-binding protein-3 and cancer risk: evidence from 96 studies.
Chen W; Wang S; Tian T; Bai J; Hu Z; Xu Y; Dong J; Chen F; Wang X; Shen H
Eur J Hum Genet; 2009 Dec; 17(12):1668-75. PubMed ID: 19491931
[TBL] [Abstract][Full Text] [Related]
19. Role of IGF1-(CA)19 promoter microsatellite in the clinical presentation of acromegaly.
Sala E; Filopanti M; Ferrante E; Barbieri AM; Malchiodi E; Verrua E; Giavoli C; Lania AG; Arosio M; Beck-Peccoz P; Spada A; Mantovani G
Eur J Clin Invest; 2014 Dec; 44(12):1222-9. PubMed ID: 25370837
[TBL] [Abstract][Full Text] [Related]
20. Variation in plasma insulin-like growth factor-1 and insulin-like growth factor binding protein-3: genetic factors.
Morimoto LM; Newcomb PA; White E; Bigler J; Potter JD
Cancer Epidemiol Biomarkers Prev; 2005 Jun; 14(6):1394-401. PubMed ID: 15941947
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
